Latest data from June 17, 2022
Number of Health Center respondents = 59 (82% of all Health Centers)
Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.
Patients Tested
| Metrics | Value |
|---|---|
| Patients Tested for COVID-19, Virus Detection (PCR, Antigen)1 | 7,009 |
| Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, Antigen) | 80.87% |
| Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen)1 | 1,305 |
| Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen) | 79.18% |
Patients by Race and Ethnicity
| Race/Ethnicity | Patients Tested, Virus Detection (PCR, Antigen)2 | Patients Tested Positive, Virus Detection (PCR, Antigen)2 |
|---|---|---|
| White, Non-Hispanic/Latino Patients | 17.78% | 18.77% |
| White, Hispanic/Latino Patients | 56.80% | 54.02% |
| Black/African American, Non-Hispanic/Latino Patients | 8.56% | 7.66% |
| Black/African American, Hispanic/Latino Patients | 0.56% | 0.31% |
| Asian Patients3 | 1.68% | 2.76% |
| American Indian/Alaska Native Patients3 | 0.29% | 0.31% |
| Native Hawaiian/Other Pacific Islander Patients3 | 0.30% | 0.31% |
| Patients with More Than One Race3 | 2.08% | 1.38% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 4.88% | 4.67% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 0.93% | 1.53% |
| Unreported/Refused to Report Race and Ethnicity | 6.15% | 8.28% |
Patients Vaccinated
| Metrics | Value |
|---|---|
| COVID-19 Immunization Series Initiated | 765 |
| Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization | 90.37% |
| COVID-19 Immunization Series Completed | 699 |
| Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization | 92.27% |
| COVID-19 Immunization Series Additional | 1,735 |
| Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine | 87.28% |
Vaccinations by Race and Ethnicity
| Race/Ethnicity | Patient COVID-19 Immunization Series Initiated2 | Patient COVID-19 Immunization Series Completed2 | Patient COVID-19 Immunization Series Additional2 |
|---|---|---|---|
| White, Non-Hispanic/Latino Patients | 9.15% | 7.44% | 12.10% |
| White, Hispanic/Latino Patients | 66.93% | 71.10% | 59.42% |
| Black/African American, Non-Hispanic/Latino Patients | 8.76% | 9.01% | 8.24% |
| Black/African American, Hispanic/Latino Patients | 0.92% | 0.14% | 0.17% |
| Asian Patients3 | 1.31% | 1.43% | 1.67% |
| American Indian/Alaska Native Patients3 | 0.13% | 0.29% | 2.48% |
| Native Hawaiian/Other Pacific Islander Patients3 | 0.00% | 0.14% | 0.17% |
| Patients with More Than One Race3 | 0.92% | 1.43% | 0.40% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 6.93% | 5.29% | 10.49% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 0.65% | 0.29% | 0.58% |
| Unreported/Refused to Report Race and Ethnicity | 4.31% | 3.43% | 4.27% |
Testing Logistics
Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, Antigen)
| Metrics | Value |
|---|---|
| Less Than 1 Hour | 40.68% |
| 1 to 24 Hours | 30.51% |
| More Than 24 Hours | 27.12% |
| N/A | 1.69% |
Vaccine Logistics
Challenges in Deploying the COVID Vaccine
| Metrics | Value |
|---|---|
| Financial reimbursement for costs associated with vaccine administration | 6.78% |
| Staffing to administer the vaccine | 22.03% |
| Vaccine confidence | 32.20% |
| Vaccine storage capacity | 1.69% |
| Vaccine supply | 1.69% |
| Other | 5.08% |
| None | 47.46% |
Operations and Staff
| Metrics | Value |
|---|---|
| COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program | 30.51% |
| Average Percent of Health Center Visits Conducted Virtually | 11.27% |
Mobile Vans, Pop-Up Clinics, and School-Based Sites
| Metrics | Value |
|---|---|
| Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics | 22.03% |
| Number of Mobile Van Sites | 9 |
| Number of Pop-up Clinics | 5 |
| Number of School-Based Vaccination Sites | 2 |
| Number of Family Vaccination Clinics | 36 |
Monoclonal Antibody Therapy
Methods in Providing Access to Monoclonal Antibody Therapy
| Metrics | Value |
|---|---|
| Direct provision of monoclonal antibody therapies | 1.69% |
| Refer patients to another organization that provides monoclonal antibody therapies | 57.63% |
| None | 40.68% |
Challenges in Providing Access to Monoclonal Antibody Therapy
| Metrics | Value |
|---|---|
| Access to therapeutics | 16.95% |
| Patient awareness/education | 5.08% |
| Staffing capacity | 16.95% |
| Therapy administration/onsite logistics | 23.73% |
| Other | 6.78% |
| None | 59.32% |
Test Kit Distribution
| Metrics | Value |
|---|---|
| Number of Health Centers that Distributed Test Kits Received through the HRSA COVID-19 Testing Supply Program | 29 |
| Number of Test Kits Distributed through the HRSA COVID-19 Testing Supply Program | 14,288 |
Test Kit Distribution Methods4
| Metrics | Value |
|---|---|
| Provided to Existing Health Center Patients | 86.21% |
| Provided to General Public Who Came to the Health Center | 41.38% |
| Provided at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) | 24.14% |
| Provided at Other Community Events | 24.14% |
| Provided to migratory/seasonal agricultural workers directly or through partnerships with community organizations serving these individuals | 10.34% |
| Provided to individuals with limited English proficiency directly or through partnerships with community organizations serving these individuals | 27.59% |
| Provided to older adults and/or individuals with disabilities directly or through partnerships with community organizations serving these individuals | 17.24% |
| Provided to school-age children and/or their families directly or through partnerships with schools | 24.14% |
| Provided to individuals living in HUD-assisted housing and/or individuals experiencing homelessness directly or through partnerships with local housing authorities | 13.79% |
| Other | 0.00% |
N95 Mask Distribution
| Metrics | Value |
|---|---|
| Health Centers that Distributed N95 Masks Received through the HRSA Health Center COVID-19 N95 Mask Program | 19 |
| Number of N95 Masks Distributed through the HRSA Health Center COVID-19 N95 Mask Program | 22,122 |
N95 Mask Distribution Methods5
| Metrics | Value |
|---|---|
| Provided to Existing Health Center Patients | 89.47% |
| Provided to General Public Who Came to the Health Center | 52.63% |
| Provided at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) | 31.58% |
| Provided at Other Community Events | 26.32% |
| Provided to migratory/seasonal agricultural workers directly or through partnerships with community organizations serving these individuals | 21.05% |
| Provided to individuals with limited English proficiency directly or through partnerships with community organizations serving these individuals | 42.11% |
| Provided to older adults and/or individuals with disabilities directly or through partnerships with community organizations serving these individuals | 31.58% |
| Provided to school-age children and/or their families directly or through partnerships with schools | 31.58% |
| Provided to individuals living in HUD-assisted housing and/or individuals experiencing homelessness directly or through partnerships with local housing authorities | 26.32% |
| Other | 0.00% |
Oral Antiviral Medication Distribution
| Metrics | Value |
|---|---|
| Number of Health Centers that Provided COVID-19 Oral Antiviral Medication through the HRSA Health Center COVID-19 Therapeutics Program | 10 |
| Racial and/or Ethnic Minority Patients Who Received COVID-19 Oral Antiviral Medication | 80.33% |
Oral Antiviral Medication Distribution by Race and Ethnicity
| Race/Ethnicity | Value |
|---|---|
| White, Non-Hispanic/Latino Patients | 10.88% |
| White, Hispanic/Latino Patients | 70.29% |
| Black/African American, Non-Hispanic/Latino Patients | 2.93% |
| Black/African American, Hispanic/Latino Patients | 0.00% |
| Asian Patients3 | 2.51% |
| American Indian/Alaska Native Patients3 | 0.84% |
| Native Hawaiian/Other Pacific Islander Patients3 | 0.42% |
| Patients with More Than One Race3 | 0.00% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 3.35% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 2.51% |
| Unreported/Refused to Report Race and Ethnicity | 6.28% |
Oral Antiviral Medication Distribution by Population Type
| Metrics | Value |
|---|---|
| Migratory/Agricultural Workers | 1.26% |
| Patients Experiencing Homelessness | 2.51% |
| Patients Who Are Residents of Public Housing | 2.51% |
| Patients with Limited English Proficiency | 21.34% |
| Children Under 18 Years of Age | 2.93% |
1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.
2 Percentages may not add to 100% due to rounding to the hundredths.
3 Includes Hispanic/Latino and Non-Hispanic/Latino.
4 Percentages are calculated using the number of health centers that have distributed test kits received through the HRSA COVID-19 Testing Supply Program as the denominator.
5 Percentages are calculated using the number of health centers that have distributed N95 masks received through the HRSA Health Center COVID-19 N95 Mask Program as the denominator.
Date Last Reviewed: